The 2025 Medicare Physician Fee Schedule final rule, released Nov. 1, includes a conversion factor of $32.3465, a 2.83% drop from 2024. In response to advocacy efforts from the ACR and other medical societies, Congress recently introduced the Medicare Patient Access and Practice Stabilization Act of 2024, which would eliminate the 2.83% payment cut and provide an inflationary update for 2025 equal to 50% of the Medicare Economic Index.
After Coalition Meeting, CMS Leadership Agrees to Closer Look at Underwater Biosimilars
The Underwater Biosimilars Coalition shared with the Centers for Medicare & Medicaid Services concerns about problems arising from the average sales price payment methodology and discussed potential options for addressing these challenges.
Interim AMA House of Delegates Meeting Will Discuss Rheumatology Priorities
At the November meeting, the ACR will advance a resolution that addresses increasing access to telemedicine services for Medicare beneficiaries.
The ACR Joins Members of Congress in Call for Medicare Reimbursement Reform
A letter from 233 bipartisan members of Congress last week urged House leadership to replace the 2.8% cut proposed in the FY2025 Physician Fee Schedule with an annual payment update reflective of inflationary pressures before the end of the year. Boost this effort by contacting your legislator today.
Take Action on Medicare Payment, Telehealth
Medicare physician reimbursement and extension of telehealth flexibilities are two of the ACR’s top legislative priorities as Congress approaches the lame duck session. With physicians facing a 2.8% cut under the 2025 Medicare Physician Fee Schedule proposed rule and telehealth flexibilities set to expire at the end of this year, Congress must hear from the…
Congressional Action Needed to Maintain Medicare’s Extended Telehealth Services
Medicare’s extended telehealth services will expire at the end of the year unless Congress acts to continue them. Make sure your legislators know how a failure to act will harm patient access to care.
How the ACR Helps with Reimbursement, Utilization Management & Other Practice Challenges
Improving reimbursement for underwater biosimilars is just one example of how the ACR’s practice advocates have achieved solutions to members’ insurance challenges. Here’s a look at current ACR efforts in insurance advocacy and how to get help with your own insurance challenges.
ACR Comments on 2025 Physician Fee Schedule
The ACR’s response to the Centers for Medicare & Medicaid Services addresses the likely harm of the proposed conversion factor on the solvency and stability of rheumatology practices. The comments also include recommendations on complex drug administration coding, inflation-adjusted drug rebates and extending telehealth flexibilities.
ACR-Led Coalition on Underwater Biosimilars Grows, Charts Next Steps
New members include rheumatology state societies, specialty partners in gastroenterology and patient-facing organizations representing digestive and inflammatory diseases. The ACR and coalition partners are strategizing additional steps to ensure practices receive adequate reimbursement for biosimilars.
Meet the ACR’s Advocacy Team
It’s an election year, and ACR staff are excited about the possibility of moving key initiatives, such as Medicare reimbursement, across the finish line. But they need members’ help to do so.
- 1
- 2
- 3
- …
- 8
- Next Page »